Longhorn
Vaccine and diagnostic development and manufacturing.
Based in MD
🤖
AI Overview
With $650K in lobbying spend across 12 quarterly filings, Longhorn is an active lobbying client. Their lobbying covers 1 issue area. Active from 2023 to 2025.
$650K
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $170K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Legislative and regulatory issues related vaccine and diagnostic research, development and stockpiling. The reauthorization of the Pandemic and All-Hazards Preparedness Act. Federal funding for relate
- •Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropria
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
United Assn of Journeymen & Apprentices of the Plumbing & Pipefitting Industry
$5.7M total spend
Plasma Protein Therapeutics Association
$4.8M total spend
Redwood Holdings, LLC FKA Redwood Capital Investments
$2.7M total spend
The United States Pharmacopeial Convention
$2.6M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.